Francisco Silva - 04 Nov 2021 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
VP of Research and Development, Director
Signature
/s/ Francisco Silva
Issuer symbol
BRTX
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
08 Nov 2021, 16:35:04 UTC
Next filing
16 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRTX Common Stock 148,848 04 Nov 2021 Direct F1, F2
holding BRTX Common Stock 3 04 Nov 2021 IRA F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Disposed to Issuer $0 -293,479 -100% $0.000000* 0 04 Nov 2021 Common Stock 293,794 $47.60 Direct F2, F5, F7
transaction BRTX Stock Option Award $0 +293,479 $0.000000 293,479 04 Nov 2021 Common Stock 293,479 $13.50 Direct F6, F7
transaction BRTX Stock Option Award $0 +42,059 $0.000000 42,059 04 Nov 2021 Common Stock 42,059 $13.50 Direct F8
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2, F3
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2, F3, F4
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2, F3
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2, F3
holding BRTX Stock Option 3 04 Nov 2021 Common Stock 3 $3000.00 Direct F2, F3
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2
holding BRTX Stock Option 1 04 Nov 2021 Common Stock 1 $3000.00 Direct F2
holding BRTX Stock Option 9 04 Nov 2021 Common Stock 9 $3000.00 Direct F2, F3
holding BRTX Stock Option 6 04 Nov 2021 Common Stock 6 $3000.00 Direct F2, F3
holding BRTX Stock Option 15 04 Nov 2021 Common Stock 15 $3000.00 Direct F2, F3
holding BRTX Stock Option 20 04 Nov 2021 Common Stock 20 $3000.00 Direct F2, F3
holding BRTX Stock Option 25 04 Nov 2021 Common Stock 25 $3000.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024.
F2 Reflects a 1-for-4,000 reverse split effected by the issuer on October 27, 2021.
F3 The option is currently exercisable.
F4 The option is exercisable subject to the satisfaction of certain conditions.
F5 The option vests to the extent of 146,740 shares on March 18, 2021, 73,370 shares on March 18, 2022 and 73,369 shares on March 18, 2023.
F6 The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
F7 The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with an adjusted exercise price and vesting dates.
F8 The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.